Effects and mechanism of anti IL-9 antibody on malignant ascites of hepatic car-cinoma / 中国免疫学杂志

Objective:To explore the effects and mechanism of anti IL-9 antibody on malignant ascites ( MA) of hepatic carci-noma in mice.Methods:A mouse model of MA was established by mouse H 22 cell line.45 mice were divided randomly into experi-mental group,negative control group and blank control group at 24 hours after modeling,with 15 mice in each group.The experimental group was injected intraperitoneally with anti IL-9 antibody;the negative control group was injected with isotype IgG antibody;the blank control group was injected with normal saline .The weight and behavior of the mice were measured before each injection .Five mice of each group was sacrificed at 24 hours after the last injection to measure the volume of MA .The level of VEGF,MMP-2,IL-9 and IFN-γin MA were determined with ELISA assay;the survival time of rest mice were recorded and compared .Results:The mean volume of MA of experimental group,negative control group and blank control group were (6.70±1.52)ml,(10.28±1.75)ml,(10.36±2.30) ml,respectively,the MA volume of experimental group were lower as compared to negative control group and blank control group ( P0.05 ) .Conclusion:Intraper-itoneal injection anti IL-9 antibody on H22 ascites-bearing mice can effectively inhibit the generation of the MA .The mechanism may be related to the inhibition of the expression of the VEGF and IL-9.

Antitumor effect of Hygrophorus lucorum polysaccharide on H22 bearing mice / 中草药

Objective: To study the inhibition and the mechanism of Hygrophorus lucorum polysaccharide (HLP) on H22 transplanted tumor in mice. Methods: The H22 transplanted models of mice were established. Sixty mice were divided into six groups: control, model, cytoxan (CTX, 200 mg/kg) positive control, low-, mid-, and high-dose (50, 100, and 200 mg/kg) HLP groups. On the day 2 after being inoculated with H22 tumor cells, mice were ig given HLP once daily for consecutive 10 d. And then the body weight change, tumor growth inhibitory rate, and spleen and thymus indexes were calculated; the serum levels of TNF-α, IL-2, VEGF, and albumin (Alb) were determined. The activities of SOD, GSH-Px, CAT, and the contents of GSH and MDA in liver homogenates, as well as the number of WBC were detected. Results: The tumor growth inhibitory rate of HLP was over 30%. The treatment with HLP significantly increased the body weight, spleen index, and the number of WBC, elevated the serum levels of IL-2, reduced the VEGF, promoted the hepatic SOD, GSH-Px, CAT activities, and GSH content, and decreased the MDA in liver homogenates. Conclusion: HLP has an antitumor effect on H22 transplanted tumor in mice, and the possible mechanisms may be due to its antioxidant activity, regulation of immunofunction, and anti-angiogenetic action.

Study on anti-tumor activities of ginsenoside structure modification HRG in vivo / 中国药学杂志

OBJECTIVE: To explore the anti-tumor activities of a new compound 3β,12β,20(S)-trihydroxy dammarane-3-O-β-D-glucopyranosyl (1-2)-β-D-glucopyranoside (HRG), which is a substance of ginsenoside structure modification, in vivo. METHODS: Liver cancer H22 tumor model on the chick chorioallantoic membrane (CAM) was established to observe the effects of HRG on tumor growth, the number of induced vessels and the growth inhibition rate. The implanted tumors were dyed by hematoxylin-eosin (HE), and the morphological properties were studied with light microscope. Immunohistochemistry (SP method) was used to detect the expressions of the implanted tumor's MVD and VEGF. RESULTS: HRG inhibited the tumor growth at 25, 50 and 100 μg · mL-1. Compared with the model control group, the inhibitory rates of the tumor growth were 27.73%, 50.02%, and 64.21%, respectively. HRG significantly reduced the number of tumor-induced vessels. At the same time, there existed different degree necrosis among the treatment groups, and the degree of necrosis had an inverse relationship with the number of tumor-induced vessels. In addition, HRG reduced the MVD of the implanted tumors, and decreased the expression of VEGF. CONCLUSION: HRG has good anti-tumor activities in vivo, and can significantly inhibit the growth of liver cancer H22-CAM tumor and the induction of angiogenesis. The mechanisms may be associated with lower tumor MVD and VEGF expression.

Influence of Heat Shock Treatment upon the Expression of Membrane HSP70 and Its mRNA of H22 Cell / 中国肿瘤生物治疗杂志

To identify the best inducing condition, we studied the expression of membrane protein HSP70 and mRNA of H22 cell at various temperature. Using MTT,RT-PCR, immunofluorescence and FCM techniques, we observed H22 cell survival rate, the expression of HSP70 mRNA and membrane HSP70. No effects of H22 cell survival rate under 42 ~ 43℃ was observed, but cell survival rate declined with increasing stress time at 44 ~ 45 ℃; the level of HSP70 mRNA decreased initially (0.5~4.0) hours but gradually resumed and increased from 8 to 12 hours at 42℃. Membrane HSP70 expressing cells were significently higher in heat shock treatment group than in a control group ( P

Tumor-derived HSP gp96 induces T cell responses and its significance in tumor immunity / 中国免疫学杂志

Objective:To explore the availability for tumor-derived gp96 to induce specific CTL activity of splenocytes in vitro.Methods:gp96 purified by the techniques for protein extraction and identified by SDS-PAGE gel electrophoresis and Western blot method; CD8+T cell induced by gp96 and CTL activity detected by flow cytometry, immunofluorescence technic and CCK-8 assay.Results:gp96 was identified by SDS-PAGE and Western blot; Analysis with FCM showed that the number of CD8+T cells(nearly 70%) was obviously increased after pulsed with gp96-peptide complexes as compared with that of control groups(35%,26%, P